07.09.25 -- Biopharma Packaging Insights: From Development To Commercialization

Competition in the biopharma industry is heating up. Established companies are using fast-tracked approval processes to get their drugs to market quicker, and a surge of new companies are entering the field. The push to get new drugs approved and sold is rapidly accelerating.

Review dynamics in bringing an injectable biologic to market and the top challenges that emerging companies face. Gain solutions for long-term success using packaging containment offerings and services to help mitigate risks and speed up your time to market.

Recognizing the importance of packaging development and prioritizing its role in drug development early on can help you proactively identify events that could delay your timelines and prepare you to develop strategies to overcome these risks. Learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

With the growth of advanced therapy medicinal products, there is an increased need for specialized low-temperature packaging solutions, particularly for vials and syringe systems at -50°C to ≤ -130°C. Demonstrate suitability by testing at the required temperature.

A large company sought a packaging recommendation while in their early-stage development of a monoclonal antibody biosimilar for oncology treatment. The company needed a stopper that they could rely on to maintain the high-quality standards needed for the success of their biosimilar and pipeline of future biosimilar products.

With the increasing demand for cell and gene therapies, Daikyo Crystal Zenith nested vials can help overcome the challenges of scaling up manufacturing and logistics. They offer benefits such as reduced breakage risk, compatibility with gene therapy drug products, and protection during transit.